Rhythmia Medical, Inc. is developing an innovative medical device for the treatment of cardiac arrhythmia. The medical device market for the treatment of cardiac arrhythmias exceeds $12 billion per annum within which Rhythmia is addressing the fastest growing segment representing one of the most attractive frontiers in medical devices.
Rhythmia employs an exceptionally talented team of developers and is working with a team of world class clinicians in the field of arrhythmia treatment.
Additional information about the company and the technology will be released at a later time. Please come back and visit us.
